News Focus
News Focus
Followers 56
Posts 14300
Boards Moderated 0
Alias Born 01/19/2009

Re: medcac post# 130871

Sunday, 04/02/2017 10:01:08 PM

Sunday, April 02, 2017 10:01:08 PM

Post# of 146477
First NNVC has to come up with a lead candidate that shows promise for curing something. If they can't find a lead candidate, scale-up is a non-issue.

There have been an awful lot of PR's by Seymour claiming to have signed contracts with labs for exactly this purpose of identifying a lead, but every single announced study has so far gone POOF!

Fortunately for Seymour, investors have very short memories:


February 1, 2016
- NanoViricides Signs Agreement with the University of Wisconsin for Testing of Anti-Viral Candidates
http://www.nanoviricides.com/press%20releases/2016/NanoViricides%20Signs%20Agreement%20with%20the%20University%20of%20Wisconsin%20for%20Testing%20of%20Anti-Viral%20Candidates.html

February 11, 2016 - NanoViricides Signs Agreement for Ocular Testing of Its Drug Candidates for the Treatment of Herpes Keratitis with the University of Pittsburgh
http://www.nanoviricides.com/press%20releases/2016/NanoViricides%20Signs%20Agreement%20for%20Ocular%20Testing%20of%20Its%20Drug%20Candidates%20for%20the%20Treatment%20of%20Herpes%20Keratitis%20with%20the%20University%20of%20Pittsburgh.html

February 16, 2016
- NanoViricides Signs Agreement for Ocular Testing of Its Drug Candidates for the Treatment of Herpes Keratitis with the Baylor College of Medicine
http://www.nanoviricides.com/press%20releases/2016/NanoViricides%20Signs%20Agreement%20for%20Ocular%20Testing%20of%20Its%20Drug%20Candidates%20for%20the%20Treatment%20of%20Herpes%20Keratitis%20with%20the%20Baylor%20College%20of%20Medicine.html

May 31, 2016 - NanoViricides Signs Agreement with St. Jude Children's Research Hospital for further Influenza Drug Development
http://www.nanoviricides.com/press%20releases/2016/NanoViricides%20Signs%20Agreement%20with%20St%20Jude%20Childrens%20Research%20Hospital%20for%20further%20Influenza%20Drug%20Development.html

October 31, 2016 - NanoViricides Signs Agreement with SUNY Upstate Medical Center for Testing of Its Drug Candidates for the Treatment of Shingles
http://www.nanoviricides.com/press%20releases/2016/NanoViricides%20Signs%20Agreement%20with%20SUNY%20Upstate%20Medical%20Center%20for%20Testing%20of%20Its%20Drug%20Candidates%20for%20the%20Treatment%20of%20Shingles.html

A casual stroll through the lunatic asylum shows that faith does not prove anything. Friedrich Nietzsche

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News